Navigation Links
ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering
Date:11/7/2007

FREMONT, Calif., Nov. 7 /PRNewswire-FirstCall/ -- ARYx Therapeutics, Inc. announced today that it has priced its initial public offering of 5,000,000 shares of its common stock at a price of $10.00 per share. All shares are being offered by ARYx Therapeutics. In addition, ARYx Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares to cover over-allotments, if any. ARYx Therapeutics common stock will trade on the NASDAQ Global Market under the symbol "ARYX."

The underwriters of this offering are Morgan Stanley & Co. Incorporated acting as sole book runner and lead manager, and CIBC World Markets Corp., Jefferies & Company, Inc. and Leerink Swann LLC, Inc. acting as co-managers.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 7, 2007. Any offer or sale will be made only by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated by emailing prospectus@morganstanley.com or by contacting the prospectus department at 180 Varick Street, New York, NY 10014, Attn: Prospectus Department.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation, or sale would be unlawful prior to their registration or qualification under the securities laws of any such state.

About ARYx Therapeutics Inc.

ARYx Therapeutics is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs. ARYx uses its RetroMetabolic Drug Design(TM) technology to design structurall
'/>"/>

SOURCE ARYx Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...nnects Customers with Partners Validated to Proces...roducts , Ottawa, ON (PRW...provider of products for biological sample collect...d its new global partner program. The program offe...ner community and is designed to help partners sca...
(Date:11/23/2009)... a provocative new study, a University of Utah sci... the major cause of global warming cannot be sta...ciety builds the equivalent of one new nuclear pow...ere will be any substantial near-term departure fr...e emission rates," says the new paper by Tim Garre...
(Date:11/23/2009)...onal carbon layer in which the carbon atoms are ar...omb. Carbon nanotubes are rolled-up sheets of grap...hite. Graphene boasts some very special characteri...t thermal conductor, and reconciles such conflicti...tion, graphene is impermeable to gases, which make...
(Date:11/23/2009)...ire-FirstCall/--NeogenCorporation(Nasdaq: NEOG )an...oNeogen,sBoardofDirectorsatthecompany,srecentannua...yearsofexperienceinthefood,agriculture,andtradeind...iculturaleconomicsatVirginiaTechUniversity.FromJan...riculturenegotiatorwiththerankofambassador. ,, ...
Breaking Biology Technology:DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4Polymer with honeycomb structure 2Richard T. Crowder Joins Neogen's Board of Directors 2
... Holidays often induce stress,but caring for child...ditional layer of pressure. Parents and caregivers...participate in live Web chats with,diabetes specia...ild,s,diabetes during the holidays, find social su... Fit Food, booklet for tips on healthy eating. Th...
...edarex, Inc.,(Nasdaq: MEDX ) today announced that...s Board of Directors to serve as a director on Med...n is President and CEO of Titan Pharmaceutical, In... the American Stock Exchange.,Prior to joining Tit... and,Development for Bayer Schering Pharma and a m...
...et earnings increase by almost 75% and by 52% ... All amounts are in U.S. dollars, ...m Innovations Inc.,(TSX: ATB) today announced that... quarter ended September 30, 2007, up 37.7% from U...06. Earnings before interest, taxes,depreciation a...
Other Biology Technology:New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays 2Medarex Announces Election of Marc Rubin as New Board Member 2Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 2Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 3Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 4Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 5Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 6Atrium Announces a Significant Increase in Revenues and Earnings for the Third Quarter of 2007 7
(Date:11/23/2009)...w study by the Wildlife Conservation Society says ...amp in the Republic of Congopart of the "mother lo...yearare becoming increasingly threatened by growin...ommends protection of the swamp forests adjacent t... after recent surveys confirmed that high densitie...
(Date:11/23/2009)...PAIGN, Ill. A new study provides "incontrovertibl...ba on the island of Sumatra about 73,000 years ago...s from the epicenter, researchers report. , The ...of ash into the atmosphere, leaving a crater (now ...ometers long and 35 kilometers wide. Ash from the ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Switchgrass produces biomass efficiently 2NSF provides 243 4 million to study climatically important Agulhas Current 9052 1NSF provides 243 4 million to study climatically important Agulhas Current 9052 2Prostate screening studies reviewed in European Urology July issue 50307 1Prostate screening studies reviewed in European Urology July issue 50307 2Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 1Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 2Access Pharmaceuticals Announces Commercial Launch of MuGard 28TM 29 in Greece by SpePharm 50303 3
... MIT Holding, Inc. (OTCBB: MITD), in collaboration...e successfully tested prototype designs of the pat...ce is designed to stop the development of pathogen...dly diseases such as malaria, dengue fever, and We...e available in countries where such diseases are a...
...lobal STM publishers, has entered a publishing par...RF) for the journal Estuaries and Coasts. Appeari...e in promoting research on and management of estua...ished at Springer will be February 2008. The part...07 Conference from 4-8 November 2007, in Providenc...
...honey bee queen appears to be determined to a larg...ne bees. , That is what research by scientists i...r for Behavioral Biology at North Carolina State U...post-doctoral research associate; Dr. David Tarpy,...e Extension apiculturist; and Dr. Christina Grozin...
Other Biology News:MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR 2Estuarine Research Federation chooses Springer as publishing partner 2For honey bee queens, multiple mating makes a difference 2For honey bee queens, multiple mating makes a difference 3
...tween the 500 l and 4 ml centrifugal concentrators...vaspin products with low internal surface and memb... solutions. ,Available with a choice of PES, Ce...e highest flexibility for process optimisation. ,...
Goat Anti-Human Lipocalin 2 Antibody, Unconjugated from Novus Biologicals
...ated proteins both of which function in tumor supp...dependent manner. p14^ARF^ binds to mdm2 and promo...for mdm2 modification and concurrent p53 stabiliza...ed by the exon 1Beta-encoded N-terminal domain of ...
Corning Culture Flask, 150 cm2, Tc-Treated, Angled Neck, Phenolic-Style, Sterile from Sigma-Aldrich
Biology Products: